Ebola Response Under Strain: The Congo outbreak is worsening in Ituri and North Kivu, with WHO warning it will “get worse before it gets better,” while Germany’s aid cuts and reduced WHO funding are limiting on-the-ground support. Ebola Risk for Travelers: A former CDC director says the U.S. could see sporadic Ebola cases as travel ramps up for the World Cup, amid plans for quarantine in Kenya that face legal hurdles. Hantavirus Monitoring: Reports describe hantavirus patients potentially being allowed to go home only if they accept 24/7 surveillance, highlighting how outbreak control is shifting toward strict monitoring. Organ Donation Ethics: A new two-part series spotlights organ donation through a faith lens, stressing consent, verified brain death by multiple doctors, and the role of end-of-life bioethics. Premium Eye Care Pipeline: Outlook Therapeutics says the FDA reversed an earlier rejection after its bevacizumab-vikg appeal process, setting up a June 2026 resubmission; the drug is already authorized in Europe/UK for wet AMD. IOL Quality Testing: Researchers at ARVO argue natural image analysis better reflects real-world distance vision quality than standard single-metric MTF alone, with implications for premium lens counseling. Public Health Funding Watch: Germany’s reduced contributions to WHO and BMZ scaling back voluntary health programs are raising concerns about preparedness and response capacity.